ArticleOncoimmunology2025

CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodies.

Djamila Chemlal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.